Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 118, Issue 3, 2002, Pages 755-761

  Mainou Fowler, Tryfonia ^a   Dignum, Helen ^a   Taylor, Penelope R A ^a   Dickinson, Anne M ^a   Saunders, Peter W G ^a   Proctor, Stephen J ^a   Summerfield, Geoffrey P ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

CD38 expression; Chronic lymphocytic leukaemia

Indexed keywords

CD38 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PREDNISONE; VINCRISTINE SULFATE;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0036037299     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03673.x     Document Type: Article

References (23)

1. CD38 expression defines clinical and biological characteristics in B-CLL
2. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia
3. CD38 expression identifies two distinct prognostic subsets in B-chronic lymphocytic leukaemia (B-CLL)
4. Clinical significance of CD38 expression in chronic lymphocytic leukemia
5. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
6. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia
7. Immunoglobulin V genes and CD38 expression in CLL
8. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukaemia
9. Combination versus successive single agent chemotherapy in lymphocytic lymphoma
10. Increased CD38 expression is associated with favourable prognosis in adult acute leukemia
11. Ligation of CD38 suppresses human B lymphopoiesis
12. Human CD38: A plycoprotein in research of a function
13. CD38 expression and IgVH gene mutation in B-cell chronic lymphocytic leukaemia
14. Human CD38, a cell-surface protein with multiple functions
15. Advances in the biology and treatment of B-cell chronic lymphocytic leukaemia
16. Immunophenotyping of blasts in human bone marrow
17. Multiple myeloma: Increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor prognosis
18. Discrete stages of intrathymic differentiation: Analysis of normal thymocytes and leukaemic lymphoblasts of T lineage
19. A B-lymphocyte surface molecule medicating activation and protection from apoptosis via calcium channels
20. CD38 expression is a poor predictor of VH gene mutational status and prognosis in chronic lymphocytic leukaemia
21. CD38 signalling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cellls
22. CD38 Expression distinguishes two groups of B-cell chronic lymphocytic leukaemias with different responses to anti-IgM antibodies and propensity to apoptosis
23. Chronic lymphocytic leukaemia: Staging and prognostic factors